Clinical Trials
Enrolling Trials
121-130 of 180
GAIN-BCG: Gemcitabine Alternating With INtravesical BCG Randomized Against BCG Alone for Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer
Dejarlais, Eric A
This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive bladder cancer that has come back after a period of improvement (recurrent). Gemcitabine is a chemotherapy drug that blocks the cells from making deoxyribonucleic acid (DNA) and may kill cancer cells. Intravesical BCG is a solution containing the live BCG bacteria that is placed in the bladder via a catheter (intravesical). When the solution comes into direct contact with the bladder wall, it stimulates the body's immune system which kills tumor cells. Giving gemcitabine with intravesical BCG may kill more tumor cells in patients with recurrent non-muscle invasive bladder cancer.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
13.1.2 Upgrade Testing
Larose, Eric R
New Agents
Adult
Testing functionality after upgrade. CT.Gov interface works. Research Base has no values - custom form Protocol Info- Oncology; Affiliation works, check to see if these values are the same as Research Base.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Velos Only PM Study - TEST - Post-update CTMS Message Queue moved to new DEV server.
Larose, Eric R
Testing Project Manager API after 13.1.2 upgrade
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
iRIS Insert Test
Larose, Eric R
Testing EDIT
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
CCEPH Insert Test
Testing
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
NFMC Insert Test
NFMC Insert Test
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
CPMR Insert Test UPDATE 7/16/2025
CPMR Insert Test
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Prescreen Failure (BREAST) Data Repository Project
Data Repository - IRB Expedited Approval (SP# WEI30611). For reporting purposes only Prescreen Failure (Disease Team Site Specific) in VELOS was created. Each disease site is NOT a separate IRB approved study, all data is applicable under SP# WEI30611.
MC - Chippewa Falls Center
2655 CTY HWY I
CHIPPEWA FALLS, WI 54729
MC - Wausau Center
2727 PLAZA DRIVE
WAUSAU, WI 54401
MC - Wisconsin Rapids Center
220 24TH ST SOUTH
WISCONSIN RAPIDS, WI 54494
MMC - Eau Claire Cancer Center
2200 Craig Road
Eau Claire, WI 54701
MMC - Ladysmith
906 College Ave W
Ladysmith, WI 54848
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
MMC - Minocqua
9601 TOWNLINE RD
MINOCQUA, WI 54548
MMC - Neillsville
216 Sunset Place
Neillsville, Wisconsin 54456
MMC - Rice Lake
2501 Main
Stevens Point, WI 54481
MMC - River Region at Stevens Point
MMC - Weston
3501 CRANBERRY BLVD
WESTON, WI 54476
Prescreen Failure (Cancer Control Studies) Data Repository Project
Data Repository - IRB Expedited Approval (SP# WEI30611). For reporting purposes only Prescreen Failure (Disease Team/Site Specific) in VELOS was created. Each disease site is NOT a separate IRB approved study, all data is applicable under SP# WEI30611.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449
Prescreen Failure (CCDR) Data Repository Project
Data Repository - IRB Expedited Approval (SP# WEI30611). For reporting purposes only Prescreen Failure (Disease Team/Site Specific) in VELOS was created. Each disease site is NOT a separate IRB approved study, all data is applicable under SP# WEI30611.
MMC - Marshfield
1000 N OAK AVE
MARSHFIELD, WI 54449